July 1, 2022 Experience Gracell Biotechnologies at-the-market offering The ADSs are listed on the Nasdaq Global Select Market
June 8, 2022 Experience Jiangsu Zhongnan Construction Group exchange offers and consent solicitation The exchange offers and consent solicitation are for guaranteed senior notes
May 19, 2022 Experience Laekna Therapeutics $61 million Series D financing We are advising Laekna Therapeutics in connection with its Series D financing
April 29, 2022 Experience Zhenro Properties exchange offer and consent solicitations The consent solicitations involve notes and perpetual securities
December 10, 2021 Experience CANbridge Pharmaceuticals HK$685 million IPO We advised CANbridge Pharmaceuticals on its IPO and HKEX listing
October 20, 2021 Experience MicroTech Medical HK$1.82 billion IPO We advised MicroTech Medical on its IPO and HKEX listing
October 19, 2021 Experience Abbisko HK$1.7 billion IPO We advised Abbisko on its IPO and HKEX listing
September 24, 2021 Experience Broncus Holding HK$1.55 billion IPO We advised Broncus on its IPO and HKEX listing
July 16, 2021 Experience Kindstar Globalgene Technology HK$2.21 billion IPO We advised Kindstar Global on its IPO and HKEX listing